National Coverage Analysis (NCA)

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic Syndrome

CAG-00415N

Expand All | Collapse All

Documents

Contacts

David Dolan
david.dolan@cms.hhs.gov
410-786-3365
Lead Analysts
Lead Medical Officers

History of Considerations

History Title ID
Original Consideration Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic Syndrome CAG-00415N You are here
First reconsideration Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic Syndromes (MDS) CAG-00415R View